Sarah Wordsworth
Biographic Data
| ID | 5935356 |
|---|---|
| NAME | Sarah Wordsworth |
| GIVEN NAMES | Sarah |
| FAMILY NAME | Wordsworth |
| SIGNATURE | WORDSWORTH S |
| AFFILIATIONS | University of Oxford |
| ORCID | 0000-0002-2361-3040 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 9 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2000 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Social impact bonds
Not applicable
A protocol for mobilising novel finance models for collaborative health promotion and disease prevention initiatives
Background: The prevalence of preventable non-communicable disease (NCD) underpins the need for a life-course and cross-sectoral approach to population health that is grounded in health promotion and disease prevention. European Union (EU) countries typically spend 6 to 13% of gross domestic product (GDP) on health care, yet less than 3% of this is dedicated to prevention. The extent to which spending in other sectors prevents avoidable ill-healt…
Availability and funding of clinical genomic sequencing globally
The emergence of next-generation genomic sequencing (NGS) tests for use in clinical care has generated widespread interest around the globe, but little is known about the availability and funding of these tests worldwide. We examined NGS availability across world regions and countries, with a particular focus on availability of three key NGS tests—Whole-Exome Sequencing or Whole-Genome Sequencing for diagnosis of suspected genetic diseases such a…
A cost analysis of a cancer genetic service model in the UK
Technological advances in DNA sequencing have made gene testing fast and more affordable. Evidence of effectiveness and cost-effectiveness of genetic service models is essential for the successful translation of sequencing improvements for patient benefit, but remain sparse in the genetics literature. In particular, there is a lack of detailed cost data related to genetic services. A detailed micro-costing of 28 possible pathways relating to brea…
Generic and disease-specific estimates of quality of life in macular degeneration
Sensitivity of Willingness to Pay Estimates to the Level of Attributes in Discrete Choice Experiments
This paper considers issues raised in the application of discrete choice experiments (DCEs) to estimating willingness to pay (WTP). The main issue addressed is the sensitivity of WTP estimates to the level of attributes. A DCE, concerned with preferences for alternative cervical screening programmes, was carried out with women in the Tayside area of Scotland. A split sample design was employed in which respondents were divided into two groups. Ea…
Sensitivity of Willingness to Pay Estimates to the Level of Attributes in Discrete Choice Experiments
This paper considers issues raised in the application of discrete choice experiments (DCEs) to estimating willingness to pay (WTP). The main issue addressed is the sensitivity of WTP estimates to the level of attributes. A DCE, concerned with preferences for alternative cervical screening programmes, was carried out with women in the Tayside area of Scotland. A split sample design was employed in which respondents were divided into two groups. Ea…
Sensitivity of Willingness to Pay Estimates to the Level of Attributes in Discrete Choice Experiments
This paper considers issues raised in the application of discrete choice experiments (DCEs) to estimating willingness to pay (WTP). The main issue addressed is the sensitivity of WTP estimates to the level of attributes. A DCE, concerned with preferences for alternative cervical screening programmes, was carried out with women in the Tayside area of Scotland. A split sample design was employed in which respondents were divided into two groups. Ea…
Generic and disease-specific estimates of quality of life in macular degeneration
A cost analysis of a cancer genetic service model in the UK
Technological advances in DNA sequencing have made gene testing fast and more affordable. Evidence of effectiveness and cost-effectiveness of genetic service models is essential for the successful translation of sequencing improvements for patient benefit, but remain sparse in the genetics literature. In particular, there is a lack of detailed cost data related to genetic services. A detailed micro-costing of 28 possible pathways relating to brea…
Availability and funding of clinical genomic sequencing globally
The emergence of next-generation genomic sequencing (NGS) tests for use in clinical care has generated widespread interest around the globe, but little is known about the availability and funding of these tests worldwide. We examined NGS availability across world regions and countries, with a particular focus on availability of three key NGS tests—Whole-Exome Sequencing or Whole-Genome Sequencing for diagnosis of suspected genetic diseases such a…
A protocol for mobilising novel finance models for collaborative health promotion and disease prevention initiatives
Background: The prevalence of preventable non-communicable disease (NCD) underpins the need for a life-course and cross-sectoral approach to population health that is grounded in health promotion and disease prevention. European Union (EU) countries typically spend 6 to 13% of gross domestic product (GDP) on health care, yet less than 3% of this is dedicated to prevention. The extent to which spending in other sectors prevents avoidable ill-healt…
Social impact bonds
Not applicable
Medicine (4 works) · Public health (3 works) · Biology (2 works) · Business (2 works) · Cancer Genomics and Diagnostics (2 works) · Community Development and Social Impact (2 works) · Computer Science (2 works) · Economic and Environmental Valuation (2 works) · Economic growth (2 works) · Economics (2 works)